Latest Insider Transactions at Signify Health, Inc. (SGFY)
This section provides a real-time view of insider transactions for Signify Health, Inc. (SGFY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Signify Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Signify Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2023
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,660
-1.84%
|
$158,480
$28.37 P/Share
|
|
Feb 27
2023
|
Tim Gronniger Ch. Value-Based Sols. Off |
BUY
Grant, award, or other acquisition
|
Direct |
86,836
+20.96%
|
-
|
|
Feb 27
2023
|
Adam Mc Ananey General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
52,102
+28.03%
|
-
|
|
Feb 27
2023
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Grant, award, or other acquisition
|
Direct |
86,836
+21.99%
|
-
|
|
Feb 27
2023
|
David Pierre Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,836
+29.68%
|
-
|
|
Feb 27
2023
|
Josh Builder Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,836
+39.88%
|
-
|
|
Feb 27
2023
|
Marc D Rothman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,735
+32.86%
|
-
|
|
Feb 27
2023
|
Laurence Michael Orton Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,894
+29.07%
|
-
|
|
Feb 27
2023
|
Paymon Farazi Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,836
+26.79%
|
-
|
|
Feb 27
2023
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
295,242
+43.22%
|
-
|
|
Dec 30
2022
|
Arnold Goldberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
633
+1.9%
|
-
|
|
Dec 30
2022
|
Taj J. Clayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
633
+2.36%
|
-
|
|
Nov 03
2022
|
Paymon Farazi Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
103,058
+40.66%
|
-
|
|
Nov 03
2022
|
Tim Gronniger Ch. Value-Based Sols. Off |
BUY
Grant, award, or other acquisition
|
Direct |
68,705
+22.21%
|
-
|
|
Sep 30
2022
|
Arnold Goldberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
622
+1.9%
|
-
|
|
Sep 30
2022
|
Taj J. Clayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
622
+2.38%
|
-
|
|
Aug 03
2022
|
Paymon Farazi Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,375
+50.0%
|
-
|
|
Jun 30
2022
|
Arnold Goldberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,314
+4.01%
|
-
|
|
Jun 30
2022
|
Taj J. Clayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,314
+5.01%
|
-
|
|
May 19
2022
|
Vivian E. Riefberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,672
+28.68%
|
-
|
|
May 19
2022
|
Kevin M Mcnamara Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,672
+39.38%
|
-
|
|
May 19
2022
|
Brandon H Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,672
+28.68%
|
-
|
|
May 19
2022
|
Taj J. Clayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,672
+38.35%
|
-
|
|
May 19
2022
|
Albert A Notini Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,672
+50.0%
|
-
|
|
May 19
2022
|
Kyle B. Peterson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,672
+50.0%
|
-
|
|
May 19
2022
|
Matthew S. Holt Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,672
+50.0%
|
-
|
|
May 19
2022
|
Arnold Goldberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,672
+32.72%
|
-
|
|
May 19
2022
|
Heather Brianne Dixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,672
+33.09%
|
-
|
|
May 19
2022
|
New Mountain Capital, L.L.C. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
44,016
+39.38%
|
-
|
|
May 09
2022
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
8,320
+8.24%
|
$91,520
$11.77 P/Share
|
|
May 09
2022
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Open market or private purchase
|
Direct |
2,500
+1.14%
|
$27,500
$11.75 P/Share
|
|
May 06
2022
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Open market or private purchase
|
Direct |
10,000
+4.44%
|
$120,000
$12.55 P/Share
|
|
Mar 31
2022
|
Taj J. Clayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
999
+10.08%
|
-
|
|
Mar 31
2022
|
Arnold Goldberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
999
+6.05%
|
-
|
|
Mar 07
2022
|
David Pierre Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,709
+47.06%
|
-
|
|
Mar 07
2022
|
Laurence Michael Orton Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,800
+42.53%
|
-
|
|
Mar 07
2022
|
Adam Mc Ananey General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
44,046
+35.04%
|
-
|
|
Mar 07
2022
|
Marc D Rothman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,237
+49.3%
|
-
|
|
Mar 07
2022
|
Josh Builder Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,046
+50.0%
|
-
|
|
Mar 07
2022
|
Peter Boumenot Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,237
+50.0%
|
-
|
|
Mar 07
2022
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,473
+45.51%
|
-
|
|
Mar 07
2022
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Grant, award, or other acquisition
|
Direct |
70,473
+25.57%
|
-
|
|
Mar 07
2022
|
Laurel Douty EVP, Clinic. Ops, Care Srvces |
BUY
Grant, award, or other acquisition
|
Direct |
44,046
+44.9%
|
-
|
|
Feb 16
2022
|
Matthew S. Holt Director |
SELL
Other acquisition or disposition
|
Direct |
7,916
-100.0%
|
-
|
|
Feb 16
2022
|
Albert A Notini Director |
SELL
Other acquisition or disposition
|
Direct |
7,916
-100.0%
|
-
|
|
Feb 16
2022
|
Kyle B. Peterson Director |
SELL
Other acquisition or disposition
|
Direct |
7,916
-100.0%
|
-
|
|
Nov 22
2021
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Open market or private purchase
|
Direct |
2,500
+1.82%
|
$32,500
$13.27 P/Share
|
|
Nov 17
2021
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Open market or private purchase
|
Direct |
10,000
+7.04%
|
$140,000
$14.92 P/Share
|
|
Nov 16
2021
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Open market or private purchase
|
Direct |
10,000
+7.57%
|
$150,000
$15.32 P/Share
|
|
Aug 25
2021
|
Arnold Goldberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,662
+50.0%
|
-
|